Skip to main content

Table 1 Comparison of the baseline characteristics among patients

From: Wellens’ syndrome: incidence, characteristics, and long-term clinical outcomes

Variables

Wellens’ (N = 200)

Non-Wellens’ (N = 1927)

P value

Age (years)

63.3 ± 10.4

64.2 ± 9.7

0.158

Male

146 (73)

1314 (68.2)

0.163

Days

6 (5.8)

6 (4.7)

< 0.001

BMI (kg/m2)

25.21 ± 2.97

25.93 ± 3.45

0.005

WC (cm)

90.79 ± 9.84

92.5 ± 10.08

0.025

Smoking

114 (57)

1017 (55.8)

0.255

HT

133 (66.5)

1353 (70.2)

0.276

DM

70 (35)

810 (42)

0.055

Hyperlipemia

100 (50)

1030 (53.5)

0.352

History of CHD

46 (23)

763 (39.6)

< 0.001

Prior MI

15 (7.5)

199 (10.3)

0.206

HF

1 (0.5)

13 (0.7)

0.771

CKD

10 (5)

71 (3.7)

0.355

PAD

14 (7)

202 (10.5)

0.121

Stroke

39 (19.5)

317 (16.5)

0.271

Previous PCI

18 (9)

376 (19.5)

< 0.001

NSTEMI

138 (69)

338 (17.5)

< 0.001

EDD (cm)

5.19 ± 0.56

5.08 ± 0.52

0.006

LVEF

0.62 ± 0.09

0.65 ± 0.08

0.002

LDL-C (mmol/L)

2.5 ± 0.73

2.25 ± 0.75

< 0.001

eGFR (ml/min)

86.69 ± 24.76

88.09 ± 22.2

0.408

HBA1c (%)

6.54 ± 1.46

6.7 ± 21.45

0.159

Multivessel disease

177 (88.5)

1712 (88.8)

0.884

LM disease

18 (9)

229 (11.9)

0.226

Plain balloon angioplasty

7 (3.5)

279 (14.6)

< 0.001

Drug-eluting stent

193 (96.5)

1635 (84.8)

< 0.001

Stent length < 30 mm

58 (29)

542 (28.1)

0.794

Number of stents

1.35 ± 0.63

1.14 ± 0.69

< 0.001

Early PCI (< 48 h after first presentation)

136 (68)

1143 (59.3)

0.017

  1. Bold values indicate that the difference is statistically significant (P < 0.05)
  2. Data are presented as absolute numbers and percentages (for categorical variables) or mean value ± SD (for continuous variables) unless otherwise specified
  3. BMI, body mass index; WC, waist circumference; HT, hypertension; DM, diabetes mellitus; CHD, coronary heart disease; MI, myocardial infarction; HF, heart failure; CKD, chronic kidney disease; PAD, peripheral arterial disease; PCI, percutaneous coronary intervention; NSTEMI, non-ST‑elevation myocardial infarction; EDD, left ventricular end diastolic dimension; LVEF, left ventricular ejection fraction; LDL-C, low-density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate (calculated via Modification of Diet in Renal Disease equation); HbA1c, glycated hemoglobin, LM, left main